Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank33
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-73.06M
↓ 35% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-54.27M
Historical baseline
PeriodValueYoY Change
TTM$-73.06M+14.4%
2025$-85.35M+29.9%
2024$-121.69M+11.3%
2023$-137.21M-10.8%
2022$-123.84M-13.0%
2021$-109.57M-163.1%
2020$-41.64M-213.3%
2019$36.74M-58.4%
2018$88.33M+258.9%
2017$24.61M-